RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 97 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q1 2016. The put-call ratio across all filers is 4.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $668,000 | +135.2% | 74,437 | +40.9% | 0.00% | – |
| Q2 2016 | $284,000 | -34.7% | 52,830 | -44.1% | 0.00% | – |
| Q1 2016 | $435,000 | +3.6% | 94,555 | +17.0% | 0.00% | – |
| Q4 2015 | $420,000 | -67.6% | 80,797 | -62.3% | 0.00% | – |
| Q3 2015 | $1,295,000 | -33.5% | 214,233 | +73.5% | 0.00% | -100.0% |
| Q2 2015 | $1,948,000 | +190.3% | 123,448 | +100.1% | 0.00% | – |
| Q1 2015 | $671,000 | +165.2% | 61,690 | +156.6% | 0.00% | – |
| Q4 2014 | $253,000 | +1104.8% | 24,043 | +993.4% | 0.00% | – |
| Q3 2014 | $21,000 | -69.1% | 2,199 | -62.5% | 0.00% | – |
| Q2 2014 | $68,000 | -86.6% | 5,867 | -88.4% | 0.00% | -100.0% |
| Q1 2014 | $507,000 | +18.2% | 50,693 | +53.9% | 0.00% | – |
| Q4 2013 | $429,000 | +149.4% | 32,942 | +186.3% | 0.00% | – |
| Q3 2013 | $172,000 | +1223.1% | 11,506 | +747.3% | 0.00% | – |
| Q2 2013 | $13,000 | – | 1,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trellus Management Company, LLC | 63,500 | $1,003,000 | 1.13% |
| Broadfin Capital, LLC | 1,319,883 | $20,841,000 | 1.12% |
| BAILARD, INC. | 160,000 | $2,526,000 | 0.39% |
| Birchview Capital, LP | 46,000 | $726,000 | 0.38% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,182,167 | $18,666,000 | 0.38% |
| Rock Springs Capital Management LP | 305,000 | $4,816,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 206,500 | $3,261,000 | 0.32% |
| GLOBEFLEX CAPITAL L P | 109,771 | $1,733,000 | 0.32% |
| GROUP ONE TRADING, L.P. | 1,319,766 | $20,839,000 | 0.29% |
| Perceptive Advisors | 264,204 | $4,172,000 | 0.25% |